1. Home
  2. PMEC vs NMTC Comparison

PMEC vs NMTC Comparison

Compare PMEC & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primech Holdings Ltd.

PMEC

Primech Holdings Ltd.

HOLD

Current Price

$0.44

Market Cap

30.4M

Sector

N/A

ML Signal

HOLD

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$1.62

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMEC
NMTC
Founded
1984
2009
Country
Singapore
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.4M
29.2M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
PMEC
NMTC
Price
$0.44
$1.62
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.90
AVG Volume (30 Days)
164.8K
57.6K
Earning Date
07-24-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.43
EPS
N/A
N/A
Revenue
N/A
$9,097,692.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$31.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
163.47
52 Week Low
$0.31
$0.55
52 Week High
$2.44
$5.40

Technical Indicators

Market Signals
Indicator
PMEC
NMTC
Relative Strength Index (RSI) 40.22 N/A
Support Level N/A N/A
Resistance Level $0.80 N/A
Average True Range (ATR) 0.07 0.00
MACD -0.00 0.00
Stochastic Oscillator 35.90 0.00

Price Performance

Historical Comparison
PMEC
NMTC

About PMEC Primech Holdings Ltd.

Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Share on Social Networks: